https://fti.vc/en/news/regcell-secures-44-million-series-a-financing-to-advance-treg-cell-therapies-for-autoimmune-diseases 2026-09-25T12:35:28Z https://fti.vc/en/news/neusignal-therapeutics-selected-for-forbes-asia-100-to-watch-2026 2026-09-25T12:35:28Z https://fti.vc/en/news/neusignal-therapeutics-completes-series-b-financing-to-advance-alzheimers-disease-program-ntx-083 2026-09-25T12:35:28Z https://fti.vc/en/news/sonire-therapeutics-initiates-first-u-s-clinical-trial-of-ultrasound-guided-hifu-therapy-in-pancreatic-cancer 2026-09-25T12:35:28Z https://fti.vc/en/news/novaccel-secures-financing-to-accelerate-medical-radioisotope-production-for-next-generation-cancer-therapy 2026-09-25T12:35:28Z https://fti.vc/en/news/fti-invests-in-qoly-corporation-to-advance-microsurgery-robotics 2026-09-25T12:35:28Z https://fti.vc/en/news/airna-doses-first-patient-in-global-phase-1-study-of-rna-editing-candidate-air-001-for-aatd 2026-09-25T12:35:28Z https://fti.vc/en/news/storm-therapeutics-secures-56-million-series-c-financing-and-doses-first-patient-in-phase-2-sarcoma-trial-of-stc-15 2026-09-25T12:35:28Z https://fti.vc/en/news/sonire-therapeutics-closes-18-million-series-a-to-advance-hifu-therapy-for-pancreatic-cancer 2026-09-25T12:35:28Z https://fti.vc/en/news/neusignal-therapeutics-completed-ntx-083-phase-1-trial 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-closes-approx-130musd-fund-iv-to-advance-healthcare-innovation 2026-09-25T12:35:28Z https://fti.vc/en/news/fti-portfolio-company-regcells-scientific-founder-professor-shimon-sakaguchi-awarded-the-2025-nobel-prize-in-physiology-or-medicine 2026-09-25T12:35:28Z https://fti.vc/en/news/metagen-therapeutics-reports-clinical-readout-from-ulcerative-colitis-fmt-study 2026-09-25T12:35:28Z https://fti.vc/en/news/neusignal-therapeutics-completes-first-in-human-study-of-ntx-083-in-healthy-volunteers 2026-09-25T12:35:28Z https://fti.vc/en/news/astellas-exercises-option-to-license-small-molecules-discovered-through-joint-research-on-novel-target-with-alivexis 2026-09-25T12:35:28Z https://fti.vc/en/news/sonire-receives-fda-ide-approval-for-ultrasound-guided-hifu-device-in-unresectable-pancreatic-cancer 2026-09-25T12:35:28Z https://fti.vc/en/news/fti-makes-follow-on-investment-in-global-vasculars-series-b-to-advance-first-in-human-trials-of-biostealth-stent 2026-09-25T12:35:28Z https://fti.vc/en/news/japanese-prime-minister-shigeru-ishiba-met-select-biopharma-leaders 2026-09-25T12:35:28Z https://fti.vc/en/news/airna-raised-155m-usd-to-advance-rna-editing-therapeutics 2026-09-25T12:35:28Z https://fti.vc/en/news/fti-co-leads-45-8m-usd-investment-in-regcell-to-accelerate-development-of-treg-therapy-for-autoimmune-diseases 2026-09-25T12:35:28Z https://fti.vc/en/news/fti-announces-additional-investment-in-neusignal-therapeutics-to-develop-alzheimers-treatment 2026-09-25T12:35:28Z https://fti.vc/en/news/alivexis-secures-800m-jpy-in-series-d-funding-to-propel-drug-discovery-innovations 2026-09-25T12:35:28Z https://fti.vc/en/news/sonire-therapeutics-receives-fda-breakthrough-device-designation-for-hifu-pancreatic-cancer-treatment 2026-09-25T12:35:28Z https://fti.vc/en/news/airna-raised-oversubscribed-financing-to-advance-rna-editing-therapeutics 2026-09-25T12:35:28Z https://fti.vc/en/news/abbvie-acquires-celsius-therapeutics 2026-09-25T12:35:28Z https://fti.vc/en/news/alivexis-and-melodia-therapeutics-join-forces-to-advance-innovative-therapies 2026-09-25T12:35:28Z https://fti.vc/en/news/medii-raises-series-a-funding-to-enhance-e-consult-an-exclusive-online-consultation-service-for-physicians 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-fti-invests-in-shinobi-therapeutics-a-u-s-and-japan-based-company-developing-hypoimmune-ips-cell-therapy 2026-09-25T12:35:28Z https://fti.vc/en/news/global-vascular-secures-series-a-funding-to-advance-innovative-nanotechnology-for-peripheral-artery-disease-treatment 2026-09-25T12:35:28Z https://fti.vc/en/news/shinobi-and-neusignal-for-ameds-funding-program 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-invests-830m-jpy-in-cellfiber-pioneering-cell-mass-production-technology 2026-09-25T12:35:28Z https://fti.vc/en/news/airna-launches-to-develop-rna-editing-therapeutics-for-rare-and-common-diseases 2026-09-25T12:35:28Z https://fti.vc/en/news/celsius-therapeutics-announces-initiation-of-dosing-in-phase-1-clinical-trial-of-cel383-an-anti-trem1-antibody-for-the-treatment-of-inflammatory-bowel-disease 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-signs-alliance-agreement-with-an-venture-partners 2026-09-25T12:35:28Z https://fti.vc/en/news/koji-yasuda-has-been-appointed-as-principal-of-fast-track-initiative-at-its-boston-office 2026-09-25T12:35:28Z https://fti.vc/en/news/tai-harada-has-been-appointed-as-partner-at-fast-track-initiative 2026-09-25T12:35:28Z https://fti.vc/en/news/purec-partners-with-mochida-pharmaceutical-to-manufacture-its-high-purity-mesenchymal-stem-cells-towards-the-treatment-of-metabolic-bone-diseases 2026-09-25T12:35:28Z https://fti.vc/en/news/metagen-therapeutics-announces-initial-closing-of-series-a-introducing-an-unprecedented-potential-of-microbiome-therapeutics 2026-09-25T12:35:28Z https://fti.vc/en/news/sonire-therapeutics-begins-a-randomized-phase-2-clinical-study-for-patients-with-unresectable-pancreatic-cancer 2026-09-25T12:35:28Z https://fti.vc/en/news/rin-institute-announces-first-in-human-dose-of-rn-1101-a-monoclonal-antibody-for-colorectal-cancer-treatment-in-phase-i-clinical-trial 2026-09-25T12:35:28Z https://fti.vc/en/news/storm-therapeutics-is-harnessing-the-power-of-rna-modification-to-treat-cancer-and-other-diseases 2026-09-25T12:35:28Z https://fti.vc/en/news/additional-investment-in-sonire-therapeutics-which-promotes-the-development-of-cancer-treatment-devices-using-high-intensity-focused-ultrasound-hifu 2026-09-25T12:35:28Z https://fti.vc/en/news/metagen-therapeutics-announces-pre-series-a-funding-for-its-microbiome-drug-discovery 2026-09-25T12:35:28Z https://fti.vc/en/news/pentas-receives-pmda-approval-for-commercialization-for-cerebral-aneurysm-treatment 2026-09-25T12:35:28Z https://fti.vc/en/news/varinos-announces-series-c-funding-round-raising-600m-jpy 2026-09-25T12:35:28Z https://fti.vc/en/news/mediphone-raises-over-1-1b-jpy-aiming-to-resolve-language-barriers-in-medical-care 2026-09-25T12:35:28Z https://fti.vc/en/news/cellshoot-therapeutics-develops-groundbreaking-cell-analysis-technology-for-new-drug-discovery-announcing-230m-jpy-in-seed-funding-round 2026-09-25T12:35:28Z https://fti.vc/en/news/reversasp-therapeutics-completes-its-seed-round-funding-totaling-600m-jpy 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-is-selected-as-a-certified-vc-fund-by-amed-to-propel-the-japanese-drug-development-ecosystem 2026-09-25T12:35:28Z https://fti.vc/en/news/luca-science-raises-30-3-million-in-oversubscribed-series-b-financing 2026-09-25T12:35:28Z https://fti.vc/en/news/fast-track-initiative-expands-to-the-united-states 2026-09-25T12:35:28Z